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Abstract Flavonoids are bioactive food compounds with
potential lipid-lowering effects. Commercially available enzy-
matic assays are widely used to determine free fatty acid (FFA)
and triglyceride (TG) levels both in vivo in plasma or serum
and in vitro in cell culture medium or cell lysate. However, we
have observed that various flavonoids interfere with perox-
idases used in these enzymatic assays, resulting in incorrect
l o w e rF F Aa n dT Gl e v e l st h a na c t u a l l yp r e s e n t .F u r t h e r m o r e ,
addition of isorhamnetin or the major metabolite of the
flavonoid quercetin in human and rat plasma, quercetin-3-O-
glucuronide, to murine serum also resulted in a significant
reduction of the detected TG levels, while a trend was seen for
FFA levels. It is concluded that when applying these assays,
vigilance is needed and alternative analytical methods, directly
assessing FFA or TG levels, should be used for studying the
biological effects of flavonoids on FFA and TG levels.
Keywords Free fatty acids.Triglycerides.Enzymatic
assays.Flavonoids.Peroxidase
Introduction
Free fatty acid (FFA) and triglyceride (TG) plasma levels
are important factors which can give an indication of the
metabolic health status and are therefore generally used as
markers of lipid metabolism. Commercially available
enzymatic kits are widely used to determine FFA and TG
levels. There are many advantages for the use of these
assays, including small sample volume, no need for
extraction, and high sensitivity [1]. Flavonoids are natural
food compounds which are suggested to have beneficial
lowering effects on lipid status [2]. Several studies
investigated the effects of flavonoids on FFA and TG
levels after dietary intervention or cell culture exposure and
used these enzymatic kits to determine the lipid levels in
serum cq. cell culture medium [3–9]. FFA and TG assays
are based on enzymatic reactions. Independent of the
supplier of the kits, peroxidase catalyzes the final quanti-
tative conversion to the colored compound, which is
subsequently measured by absorbance in both of these
assays. Furthermore, also other frequently used enzymatic
assays for the determination of, for example, cholesterol
and glucose are based on peroxidase reactions.
In the FFA assay, FFAs are transformed into Acyl-coA,
which is oxidized and generates hydrogen peroxide. In a
quantitative oxidation reaction, hydrogen peroxide together
with 3-methyl-N-ethyl-N-(β-hydroxyethyl) aniline and 4-
aminoantipyrine (4-AA) are converted into a blue purple
product by peroxidase activity. Absorbance is used to
quantify the FFA levels. In the TG assay, TGs are
hydrolyzed with lipases generating glycerol, which is
converted into glycerol-3-phosphate and oxidized generat-
ing hydrogen peroxide. Hydrogen peroxide and 4-AA are
converted into quinoneimine catalyzed by peroxidase.
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Interference of flavonoids with enzymatic assays
for the determination of free fatty acid and triglyceride levelsAbsorbance of quinoneimine is used to quantify the TG
levels. It is clear that peroxidase has an important role in
both assays because it catalyzes the final quantitative
reaction. Importantly, flavonoids are known to be inhibitors
of peroxidase activity [10–12]. Nevertheless, these assays
are widely used in (nutritional) studies focusing on the
effects of flavonoids. The inhibition of peroxidase by
flavonoids may result in reduced peroxidase-mediated color
formation, which will result in apparently lower FFA and
TG levels than actually present. Therefore, the aim of the
present study was to investigate whether at physiologically
relevant concentrations flavonoids do indeed interfere with
these widely applied peroxidase-based assays for the
quantification of FFA and TG levels.
Materials and methods
Sample preparation
Cell culture medium samples were prepared in 1× DMEM
high glucose without phenol red (Invitrogen, Breda, the
Netherlands), with 10% fetal bovine serum charcoal/dextran
treated (Thermo Scientific, Logan, Utah, USA), 2% penicil-
lin–streptomycin (Invitrogen), and 1% non-essential amino
acids (Invitrogen). Medium was supplemented with 80 μM
linoleic acid–oleic acid–albumin (Sigma, Zwijndrecht, the
Netherlands) and 20 mg/dL triglycerides standard. Quercetin,
(+)-catechin (Sigma), naringenin, luteolin, kaempferol, and
genistein (Extrasynthese, Lyon, France) were individually
spiked to cell culture medium samples in different concen-
trations prior to measurements.
Serum samples obtained from Harlan Laboratories
(Horst, the Netherlands) were pooled serum of C57BL/
6JOlaHsd male mice. Quercetin, quercetin-3-O-glucuronide
(Phytolab, Vestenbergsgreuth, Germany), and isorhamnetin
(Extrasynthese) were spiked to the murine serum. All
flavonoids were dissolved in DMSO, except quercetin-3-O-
glucuronide which was dissolved in ethanol; for controls, only
the solvent was added at equal volumes.
Free fatty acids assay
FFA kit reagents (Wako NEFA-HR(2) Kit, Sopachem BV,
Ochten, the Netherlands) were used according to the
manufacturer’s protocol, with some small adaptations. The
protocol mentions several usually present compounds in
serum or plasma that may interfere with the assay; however,
information on flavonoids or other bioactive food ingre-
dients is not provided. Briefly, 5 or 15 μL of sample plus
100 μL of the first reagent were incubated for 10 min at
37 °C. Then, 50 μL of the second reagent was added and
incubated for another 10 min at 37 °C. Oleic acid (Wako
NEFA calibrator solution) was used for calibration curves.
The absorbance was read at 550 nm using a Synergy HT
plate reader (Biotek Instruments, Winooski, VT, USA).
Triglyceride assay
TG kit reagent (Triglycerides Liquicolor Kit, Human,
Wiesbaden, Germany) was used according to the manufac-
turer’s protocol. The protocol mentions several usually
present compounds in serum or plasma that may interfere
with the assay; however, information on flavonoids or other
bioactive food ingredients is not provided. Briefly, 5 μLo f
the sample plus 100 μL reagent were incubated for 10 min
at room temperature. Triglyceride standard from the kit was
used for calibration curves. The absorbance was read at
500 nm.
Statistical analysis
Statistical analysis was performed using one-way ANOVA
followed by Dunnett’s post hoc test. A p-value <0.05 was
considered significant.
Results and discussion
Individual spiking of quercetin, kaempferol, and (+)-
catechin to the cell culture medium prior to measurements
resulted in a significant reduction in the FFA levels detected
(Fig. 1). The same flavonoids as well as luteolin caused
also significant reductions in the TG levels detected. The
apparent reduction in the levels of FFA and TG in these
assays was already present at concentrations (10–100 μM)
which are generally used in in vitro studies, indicating that
these peroxidase-based assays should be used with extreme
caution under these circumstances. Different flavonoids are
known to be able to inhibit peroxidase activity [10–12] and,
thus, cause this unintentional reduction in the levels of FFA
and TG detected by these assays.
Inhibition of myeloperoxidase activity is dependent on the
presence of a hydroxyl group at the 3, 5 and 4′positions in the
structure offlavonoids and the C2–C3 double bond [12]. As a
consequence, quercetin, kaempferol, and luteolin showed
inhibition of myeloperoxidase in the following order:
quercetin>kaempferol>luteolin [12]. This corresponds with
our results, which also showed an identical interference
capacity in the FFA and TG assays. However, genistein can
also inhibit the activity of peroxidase [13], while we found
no interference of genistein in both assays (Fig. 1).
In vivo, mainly metabolites of flavonoids are present in
the circulation due to extensive intestinal and hepatic
metabolism. Therefore, we analyzed the effect of individual
spiking of quercetin, isorhamnetin, and the metabolite
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resulted in a significant reduction of the FFA and TG
levels detected (Fig. 2). Quercetin-3-O-glucuronide is the
major metabolite found in human and rat plasma [12, 14,
15]. It was previously shown that plasma concentrations of
quercetin metabolites could inhibit myeloperoxidase [12].
This result corresponds with our finding that besides
quercetin, also its metabolite, quercetin-3-O-glucuronide,
interferes with the TG and FFA assays. Addition of
quercetin-3-O-glucuronide resulted in a significant reduc-
tion in the detected TG levels, while at similar concen-
trations it did not have such a strong effect on the FFA
assay. Furthermore, isorhamnetin seems to have a stronger
effect on the FFA assay than on the TG assay at similar
concentrations. Since the concentrations of quercetin-3-O-
glucuronide resulting in these reductions of FFA and TG
levels detected are in the range that can be observed in in
vivo serum samples upon oral intake of quercetin [16],
these observations show that when these enzymatic assays
are used for in vivo studies, the results can also be
unintentionally influenced.
There are several recent rodent nutritional studies with
quercetin supplementation using these enzymatic assays to
measure FFA and/or TG levels in serum or plasma [3–9].
The reported serum quercetin levels in these studies were
between 10 and 45 μM. All studies reported decreased
serum levels of FFA and/or TG after dietary quercetin
supplementation, which could at least in part be due to the
interference of quercetin with the FFA and TG assays, as
shown in the present study. The peroxidase-based assays
for FFA and TG have also been used in human flavonoid
intervention studies, although most of them found no lipid-
lowering effects, which could be partly due to lower plasma
flavonoid levels [2, 17]. The present study showed a dose-
dependent interference of various flavonoids and of an
important in vivo quercetin metabolite with peroxidase-
based assays for the detection of FFA and TG levels.
Therefore, the results of studies reporting a reduction in
Fig. 1 Interference of different
flavonoids on the FFA (a) and
TG (b) levels in the cell culture
medium measured by enzymatic
assays. (+)-Catechin (filled
square), quercetin (empty
square), kaempferol (filled
triangle), luteolin (empty trian-
gle), genistein (filled circle),
and naringenin (empty circle).
Results are mean±SEM,
n=3 for FFA and n=4 for TG.
Asterisk indicates a significant
difference (p<0.05) from the
control (0 μM). b Quercetin has
already a significant effect at
10 μM
Fig. 2 Interference of quercetin
(empty square) and its major
metabolite, quercetin-3-O-
glucuronide (filled square), and
isorhamnetin (circle) in murine
serum on the FFA (a) and TG
(b) levels measured by enzy-
matic assays. Results are mean±
SEM, n=8. Asterisk indicates a
significant difference (p<0.05)
from the control (0 μM)
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should be interpreted with caution when these assays are
used. Nevertheless, this does not exclude the biological effects
on FFA and TG levels by flavonoids as effects are also
perceived by the use of other analytical techniques [18, 19].
In conclusion, peroxidase-based enzymatic FFA and TG
assays should be applied with caution in studies focusing
on the effects of flavonoids. Interference of flavonoids and
their metabolites with peroxidases used in these assays
results in apparently lower levels of FFA and TG detected
than actually present. Most likely, this will also hold for
other enzymatic kits using peroxidase reactions, such as
total cholesterol and glucose assays. Vigilance is needed
and alternative methods including LC-MS, gas chromatog-
raphy, or
1H NMR should be used in studies focusing on
the effects of flavonoids on lipid status.
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